Article Information
History
- September 21, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nicole E. Skinner1,
- Clinton O. Ogega1,
- Nicole Frumento1,
- Kaitlyn E. Clark1,
- Srinivasan Yegnasubramanian2,
- Andrea L. Cox1,2,
- James E. Crowe Jr.3,4,5,
- Stuart C. Ray1,2 and
- Justin R. Bailey1,*
- 1Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States
- 2Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD
- 3Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center; Nashville, TN, United States
- 4Department of Pediatrics, Vanderbilt University Medical Center; Nashville, TN, United States
- 5Vanderbilt Vaccine Center, Vanderbilt University Medical Center; Nashville, TN, United States
- ↵*Address correspondence to:
Justin R. Bailey, MD, PhD, 855 N. Wolfe Street, Rangos Building, Suite 520, Baltimore, MD 21205, USA, Phone: 410-614-6087, Email: jbailey7{at}jhmi.edu
Posted September 21, 2021.
Convergent antibody responses associated with broad neutralization of hepatitis C virus and clearance of infection
